These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 9236731)
21. Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine. den Boer JA; Westenberg HG; De Leeuw AS; van Vliet IM Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():47-52. PubMed ID: 7622824 [TBL] [Abstract][Full Text] [Related]
23. Effects of selective serotonin reuptake inhibitors on thought-action fusion, metacognitions, and thought suppression in obsessive-compulsive disorder. Besiroglu L; Çetinkaya N; Selvi Y; Atli A Compr Psychiatry; 2011; 52(5):556-61. PubMed ID: 21109243 [TBL] [Abstract][Full Text] [Related]
24. SSRIs in the treatment of obsessive-compulsive disorder. Cartwright C; Hollander E Depress Anxiety; 1998; 8 Suppl 1():105-13. PubMed ID: 9809222 [TBL] [Abstract][Full Text] [Related]
25. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders. Gunasekara NS; Noble S; Benfield P Drugs; 1998 Jan; 55(1):85-120. PubMed ID: 9463792 [TBL] [Abstract][Full Text] [Related]
26. Genetic and pharmacogenetic study of glutamate transporter (SLC1A1) in Iranian patients with obsessive-compulsive disorder. Abdolhosseinzadeh S; Sina M; Ahmadiani A; Asadi S; Shams J J Clin Pharm Ther; 2019 Feb; 44(1):39-48. PubMed ID: 30315580 [TBL] [Abstract][Full Text] [Related]
27. Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders. Hoehn-Saric R; Ninan P; Black DW; Stahl S; Greist JH; Lydiard B; McElroy S; Zajecka J; Chapman D; Clary C; Harrison W Arch Gen Psychiatry; 2000 Jan; 57(1):76-82. PubMed ID: 10632236 [TBL] [Abstract][Full Text] [Related]
28. Fluvoxamine in the treatment of obsessive compulsive disorder. Montgomery SA; Manceaux A Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():5-9. PubMed ID: 1355499 [TBL] [Abstract][Full Text] [Related]
29. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors. Maina G; Albert U; Salvi V; Bogetto F J Clin Psychiatry; 2004 Oct; 65(10):1365-71. PubMed ID: 15491240 [TBL] [Abstract][Full Text] [Related]
30. Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder. Dell'Osso B; Allen A; Hollander E Expert Opin Pharmacother; 2005 Dec; 6(15):2727-40. PubMed ID: 16316311 [TBL] [Abstract][Full Text] [Related]
31. A review of pharmacologic treatments for obsessive-compulsive disorder. Kaplan A; Hollander E Psychiatr Serv; 2003 Aug; 54(8):1111-8. PubMed ID: 12883138 [TBL] [Abstract][Full Text] [Related]
32. Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive-compulsive disorder: a 5-year follow-up. van Oppen P; van Balkom AJ; de Haan E; van Dyck R J Clin Psychiatry; 2005 Nov; 66(11):1415-22. PubMed ID: 16420079 [TBL] [Abstract][Full Text] [Related]
33. Plasma tryptophan levels and tryptophan/neutral amino acid ratios in obsessive-compulsive patients with and without depression. Bellodi L; Erzegovesi S; Bianchi L; Lucini V; Conca R; Lucca A Psychiatry Res; 1997 Mar; 69(1):9-15. PubMed ID: 9080540 [TBL] [Abstract][Full Text] [Related]
34. [Treatment of comorbid obsessive-compulsive and depressive disorders in children age]. Goriunov AV; Lobacheva MV Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(11 Pt 2):48-52. PubMed ID: 23257756 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study. Mundo E; Bianchi L; Bellodi L J Clin Psychopharmacol; 1997 Aug; 17(4):267-71. PubMed ID: 9241005 [TBL] [Abstract][Full Text] [Related]
37. Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study. Pallanti S; Quercioli L; Bruscoli M J Clin Psychiatry; 2004 Oct; 65(10):1394-9. PubMed ID: 15491244 [TBL] [Abstract][Full Text] [Related]